A Phase IB/II, Open-Label, Multicenter, Randomized, Controlled Study Investigating the Safety, Tolerability, Pharmacokinetics, And Efficacy of Mosunetuzumab BTCT4465a In Combination with Chop or CHP-Polatuzumab Vedotin In Patients With B-Cell Non-Hodgkin Lymphoma

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03677141

Study #:
STUDY00142716

Start Date:
Nov 04, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03677141

View Complete Trial Details & Eligibility at ClinicalTrials.gov